Language:

Results 1 - 20 of 2,442 for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method

Results 1 2 3 4 5

Show only

Peer-reviewed Journals (2,224)

Result Number	Material Type	Record Details and Options
1	Material Type: Article	Non-neovascular age-related macular degeneration with subretinal fluid British journal of ophthalmology, 2021-10, Vol.105 (10), p.1415-1420 [Peer Reviewed Journal] Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ. ;ISSN: 0007-1161 ;EISSN: 1468-2079 ;DOI: 10.1136/bjophthalmol-2020-317326 ;PMID: 32920528 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
2	Material Type: Article	Recent developments in age-related macular degeneration: a review Clinical interventions in aging, 2017-01, Vol.12, p.1313-1330 [Peer Reviewed Journal] COPYRIGHT 2017 Dove Medical Press Limited ;COPYRIGHT 2017 Dove Medical Press Limited ;2017. This work is licensed under https://creativecommons.org/licenses/by-nc/3.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;2017 Al-Zamil and Yassin. This work is published and licensed by Dove Medical Press Limited 2017 ;ISSN: 1178-1998 ;ISSN: 1176-9092 ;EISSN: 1178-1998 ;DOI: 10.2147/CIA.S143508 ;PMID: 28860733 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
3	Material Type: Article	Early Experience With Brolucizumab Treatment of Neovascular Age-Related Macular Degeneration Archives of ophthalmology (1960), 2021-04, Vol.139 (4), p.441 [Peer Reviewed Journal] Copyright American Medical Association Apr 2021 ;ISSN: 2168-6165 ;EISSN: 1538-3601 ;DOI: 10.1001/jamaophthalmol.2020.7085 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
4	Material Type: Article	Evolution of treatment paradigms in neovascular age-related macular degeneration: a review of real-world evidence British journal of ophthalmology, 2021-11, Vol.105 (11), p.1475-1479 [Peer Reviewed Journal] Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2021 Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Attribution - NonCommercial ;Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2021 ;ISSN: 0007-1161 ;EISSN: 1468-2079 ;DOI: 10.1136/bjophthalmol-2020-317434 ;PMID: 33130553 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
5	Material Type: Article	Factors Associated With Intraocular Inflammation in Neovascular Age-Related Macular Degeneration Patients Treated With Brolucizumab Investigative ophthalmology & visual science, 2024-01, Vol.65 (1), p.8-8 [Peer Reviewed Journal] ISSN: 1552-5783 ;EISSN: 1552-5783 ;DOI: 10.1167/iovs.65.1.8 ;PMID: 38170536 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
6	Material Type: Article	Biosimilar SB11 versus reference ranibizumab in neovascular age-related macular degeneration: 1-year phase III randomised clinical trial outcomes British journal of ophthalmology, 2023-03, Vol.107 (3), p.384-391 [Peer Reviewed Journal] Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. ;2023 Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. 2023 ;ISSN: 0007-1161 ;EISSN: 1468-2079 ;DOI: 10.1136/bjophthalmol-2021-319637 ;PMID: 34656987 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
7	Material Type: Article	Effect of Residual Retinal Fluid on Visual Function in Ranibizumab-Treated Neovascular Age-Related Macular Degeneration American journal of ophthalmology, 2022-01, Vol.233, p.8-17 [Peer Reviewed Journal] 2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021. Elsevier Inc. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2021.06.029 ;PMID: 34289338 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
8	Material Type: Article	Exudation in Patients With Neovascular Age-Related Macular Degeneration Treated With the Port Delivery System or Monthly Injections American journal of ophthalmology, 2024-02, Vol.258, p.158-172 [Peer Reviewed Journal] Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2023.07.003 ;PMID: 37453472 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
9	Material Type: Article	Outcomes of Intentionally Suspending Treatment in Eyes With Advanced Neovascular Age-Related Macular Degeneration American journal of ophthalmology, 2023-12, Vol.256, p.20-26 [Peer Reviewed Journal] 2023 Elsevier Inc. ;Copyright © 2023 Elsevier Inc. All rights reserved. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2023.07.022 ;PMID: 37517527 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
10	Material Type: Article	Age-related macular degeneration The Lancet (British edition), 2018-09, Vol.392 (10153), p.1147-1159 [Peer Reviewed Journal] 2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;2018. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)31550-2 ;PMID: 30303083 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
11	$Therapeutic effects of faricimab on aflibercept-refractory age-related macular degeneration$ $Therapeutic effects of faricimab on aflibercept-refractory age-related macular degeneration$ Material Type: Article	Therapeutic effects of faricimab on aflibercept-refractory age-related macular degeneration Scientific reports, 2023-11, Vol.13 (1), p.21128-21128, Article 21128 [Peer Reviewed Journal] 2023. The Author(s). ;The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-023-48190-6 ;PMID: 38036627 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
12	Material Type: Article	One-year outcome of brolucizumab for neovascular age-related macular degeneration in Japanese patients Scientific reports, 2024-01, Vol.14 (1), p.2451-2451, Article 2451 [Peer Reviewed Journal] 2024. The Author(s). ;The Author(s) 2024. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2024 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-024-52747-4 ;PMID: 38291120 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
13	Material Type: Article	Treat & extend in neovascular age-related macular degeneration: how we got here and where do we go next? Eye (London), 2023-03, Vol.37 (4), p.581-583 [Peer Reviewed Journal] The Author(s), under exclusive licence to The Royal College of Ophthalmologists 2022. ;The Author(s), under exclusive licence to The Royal College of Ophthalmologists 2022 ;ISSN: 0950-222X ;EISSN: 1476-5454 ;DOI: 10.1038/s41433-022-02221-0 ;PMID: 36064769 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
14	Material Type: Article	Morphological changes of macular neovascularization during long-term anti-VEGF-therapy in neovascular age-related macular degeneration PloS one, 2023-12, Vol.18 (12), p.e0288861-e0288861 [Peer Reviewed Journal] Copyright: © 2023 Pauleikhoff et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. ;COPYRIGHT 2023 Public Library of Science ;ISSN: 1932-6203 ;EISSN: 1932-6203 ;DOI: 10.1371/journal.pone.0288861 ;PMID: 38134207 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
15	Material Type: Article	Pigment epithelial detachment composition indices (PEDCI) in neovascular age-related macular degeneration Scientific reports, 2023-01, Vol.13 (1), p.68-68, Article 68 [Peer Reviewed Journal] 2023. The Author(s). ;The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-022-27078-x ;PMID: 36593323 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
16	$Real-world study to evaluate the efficacy and safety of intravitreal brolucizumab for refractory neovascular age-related macular degeneration$ $Real-world study to evaluate the efficacy and safety of intravitreal brolucizumab for refractory neovascular age-related macular degeneration$ Material Type: Article	Real-world study to evaluate the efficacy and safety of intravitreal brolucizumab for refractory neovascular age-related macular degeneration Scientific reports, 2023-07, Vol.13 (1), p.11400-11400, Article 11400 [Peer Reviewed Journal] 2023. The Author(s). ;The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2023 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-023-38173-y ;PMID: 37452068 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
17	Material Type: Article	Intravitreal Aflibercept Injection vs Sham as Prophylaxis Against Conversion to Exudative Age-Related Macular Degeneration in High-risk Eyes: A Randomized Clinical Trial Archives of ophthalmology (1960), 2021-05, Vol.139 (5), p.542 [Peer Reviewed Journal] Copyright American Medical Association May 2021 ;ISSN: 2168-6165 ;EISSN: 1538-3601 ;DOI: 10.1001/jamaophthalmol.2021.0221 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
18	Material Type: Article	Real-world evidence for neovascular age-related macular degeneration: a practical approach Eye (London), 2023-01, Vol.37 (1), p.1-3 [Peer Reviewed Journal] The Author(s), under exclusive licence to The Royal College of Ophthalmologists 2022. ;The Author(s), under exclusive licence to The Royal College of Ophthalmologists 2022 ;ISSN: 0950-222X ;EISSN: 1476-5454 ;DOI: 10.1038/s41433-022-02151-x ;PMID: 35804018 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
19	Material Type: Article	Prediction of treatment outcome in neovascular age-related macular degeneration using a novel convolutional neural network Scientific reports, 2022-04, Vol.12 (1), p.5871-5871, Article 5871 [Peer Reviewed Journal] 2022. The Author(s). ;The Author(s) 2022. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2022 ;ISSN: 2045-2322 ;EISSN: 2045-2322 ;DOI: 10.1038/s41598-022-09642-7 ;PMID: 35393449 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by
20	Material Type: Article	Association Between Visual Acuity and Residual Retinal Fluid Following Intravitreal Anti–Vascular Endothelial Growth Factor Treatment for Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-analysis Archives of ophthalmology (1960), 2022-06, Vol.140 (6), p.611 [Peer Reviewed Journal] Copyright American Medical Association Jun 2022 ;ISSN: 2168-6165 ;EISSN: 1538-3601 ;DOI: 10.1001/jamaophthalmol.2022.1357 Full text available View Online Details Recommendations Reviews Times Cited External Links Citations Cited by

Results 1 - 20 of 2,442 for All Library Resources

Sorted by: Sorted by: RelevanceOr hit Enter to replace sort method

Results 1 2 3 4 5

Personalize your results

Edit

Add page to My Research

Refine Search Results

Expand My Results

Expand My Results

Show only

Peer-reviewed Journals (2,224)

on this subject:


INSPIRE LIBRARY - TON DUC THANG UNIVERSITY	(84-028) 37 755 057	Feedback
19 Nguyen Huu Tho St. Dist.7, HCM	thuvien@tdtu.edu.vn	Feedback

Results 1 - 20 of 2,442 for All Library Resources

Copyright American Medical Association Apr 2021 ;ISSN: 2168-6165 ;EISSN: 1538-3601 ;DOI: 10.1001/jamaophthalmol.2020.7085

ISSN: 1552-5783 ;EISSN: 1552-5783 ;DOI: 10.1167/iovs.65.1.8 ;PMID: 38170536

2021 Elsevier Inc. ;Copyright © 2021 Elsevier Inc. All rights reserved. ;2021. Elsevier Inc. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2021.06.029 ;PMID: 34289338

Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2023.07.003 ;PMID: 37453472

2023 Elsevier Inc. ;Copyright © 2023 Elsevier Inc. All rights reserved. ;ISSN: 0002-9394 ;EISSN: 1879-1891 ;DOI: 10.1016/j.ajo.2023.07.022 ;PMID: 37517527

2018 Elsevier Ltd ;Copyright © 2018 Elsevier Ltd. All rights reserved. ;2018. Elsevier Ltd ;ISSN: 0140-6736 ;EISSN: 1474-547X ;DOI: 10.1016/S0140-6736(18)31550-2 ;PMID: 30303083

The Author(s), under exclusive licence to The Royal College of Ophthalmologists 2022. ;The Author(s), under exclusive licence to The Royal College of Ophthalmologists 2022 ;ISSN: 0950-222X ;EISSN: 1476-5454 ;DOI: 10.1038/s41433-022-02221-0 ;PMID: 36064769

Copyright American Medical Association May 2021 ;ISSN: 2168-6165 ;EISSN: 1538-3601 ;DOI: 10.1001/jamaophthalmol.2021.0221

The Author(s), under exclusive licence to The Royal College of Ophthalmologists 2022. ;The Author(s), under exclusive licence to The Royal College of Ophthalmologists 2022 ;ISSN: 0950-222X ;EISSN: 1476-5454 ;DOI: 10.1038/s41433-022-02151-x ;PMID: 35804018

Copyright American Medical Association Jun 2022 ;ISSN: 2168-6165 ;EISSN: 1538-3601 ;DOI: 10.1001/jamaophthalmol.2022.1357

Results 1 - 20 of 2,442 for All Library Resources

Personalize your results

Refine Search Results

Expand My Results

Show only

Refine My Results

Creation Date

New Records

Resource Type

Subject

Databases

Language

Journal Title

on this subject:

Searching Remote Databases, Please Wait